Lincoln Pharmaceuticals Q4 Results
- BSE: 531633
- NSE: LINCOLN
- ISIN: INE405C01035
- Sector: Biotechnology & Drugs
BSE
617.45
-0.05 (-0.01%)
-0.05 (-0.01%)Volume1.93 K
Updated: Mon 25 Nov, 2024 | 15:28:00
NSE
617.8-0.10 (-0.02%)
-0.10 (-0.02%)Volume29.66 K
Updated: Mon 25 Nov, 2024 | 15:29:50
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Lincoln Pharmaceuticals Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 24 | Dec 22 | QoQ Comp | Mar 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 142.49 | 133.77 | -% | 112.46 | -% |
| Selling/ General/ Admin Expenses Total | 25.05 | 23.44 | -% | 23.74 | -% |
| Depreciation/ Amortization | 2.69 | 2.26 | -% | 2.41 | -% |
| Other Operating Expenses Total | 25.48 | 19.66 | -% | 23.58 | -% |
| Total Operating Expense | 126.80 | 109.28 | -% | 98.23 | -% |
| Operating Income | 15.70 | 24.49 | -% | 14.23 | -% |
| Net Income Before Taxes | 22.22 | 30.51 | -% | 16.98 | -% |
| Net Income | 18.60 | 21.61 | -% | 12.56 | -% |
| Diluted Normalized EPS | 9.28 | 10.79 | -% | 6.27 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST